Ending Age-Related Diseases Speakers 2018-2022
The Ending Age-Related Dieases (EARD) conferences are all about bringing the community together to learn about the latest developments in the field. Each year the leading experts join us to share their knowledge of research, investment, blockchain and Desci, and advocacy. You can find a list of past conference speakers below.
EARD 2022
Brian Kennedy, Ph.D.
National University Singapore - Professor of Biochemistry and Physiology
Michael Lustgarten, Ph.D.
Tufts University - Nutrition, Exercise Physiology, and Sarcopenia (NEPS) Team
Chris Mirabile
NOVOS - CEO & Co-founder
Tom Benson
Mitrix Bio - CEO
Fiona Miller
quadraScope - Managing Partner
Abdelhadi Rebbaa, Ph.D.
SENS Research Foundation - Group Lead, RepleniSENS
Matthew O'Connor
Cyclarity Therapeutics - CEO of Scientific Affairs
Michael West, Ph.D.
AgeX Therapeutics - CEO
Thach Mai, Ph.D.
Juvena Therapeutics - Lead Scientist
George Church, Ph.D.
Harvard Medical School - Professor of Genetics
Vadim Gladyshev, Ph.D.
Harvard Medical School - Professor, Medicine, Harvard Medical School
Jose Luis Ricon
Astera - Co-Founder, Rejuvenome
Steve Horvath, Ph.D.
David Geffen School of Medicine, UCLA
Varun Dwaraka, Ph.D.
TruDiagnostic - Lead Scientist
Gordan Lauc, Ph.D.
GlycanAge - CSO
Eric Morgen, M.D.
BioAge Labs - COO and Co-founder
Hanadie Yousef, Ph.D.
Juvena Therapeutics
Maddalena Adorno, Ph.D.
Dorian Therapeutics - CEO
Ashley Zehnder, Ph.D.
Fauna Bio - CEO
Glenn Markov, Ph.D.
Rejuvenation Technologies - Founder & COO
Michael Geer
Humanity - CSO
Mike P. Sinn
Crowdsourcing Cures - Founder
Kevin Perrott, Ph.D.
OpenCures - CEO
Irina Conboy, Ph.D.
UC Berkeley Research - Assistant Professor of Bioengineering
Mourad Topors, Ph.D.
Repair Biotechnologies - Chief Scientific Officer
Dylan Livingston
Alliance for Longevity Initiatives - Founder and President
S. Jay Olshansky, Ph.D.
Lapetus Solutions, Inc. - Founder
Tina Woods
Collider Health - CEO
Tobias Reichmuth, Ph.D.
Maximon - Co-Founder
Sebastian A. Brunemeier
ImmuneAGE Pharma - CEO and Co-Founder
Sergio Ruiz
Turn Biotechnologies - Chief Operating Officer
Tyler Golato
Molecule - CSO
Tim Peterson, Ph.D.
VitaDAO - Dealflow steward
Garri Zmudze
Longenesis - Board Member
EARD 2021
Eric Verdin, Ph.D.
Buck Institute for Research on Aging - President and CEO
Greg Fahy, Ph.D.
Intervene Immune - CSO
Irina Conboy, Ph.D.
UC Berkeley Research - Assistant Professor of Bioengineering
João Pedro de Magalhães, Ph.D.
University of Liverpool
Jacob C. Kimmel, Ph.D.
Calico Labs, LLC - Computational Fellow, Data Science
Kris Verburgh, M.D.
Free University of Brussels
Aubrey de Grey, Ph.D.
Methuselah Foundation - Founder
Reason
Repair Biotechnologies - CEO
Tobias Reichmuth, Ph.D.
Maximon - Co-Founder
Nathan Cheng
On Deck Longevity Biotech - Program Director
Tyler Golato
Molecule - CSO
Michael Lustgarten, Ph.D.
Tufts University - Nutrition, Exercise Physiology, and Sarcopenia (NEPS) Team
Alexandra Stolzing, Ph.D.
Loughborough University - Professor of Biogerontological Engineering
Steve Horvath, Ph.D.
David Geffen School of Medicine, UCLA
Daniel Ives, Ph.D.
Shift Bioscience - Founder and CEO
EARD 2020
Brian Kennedy, Ph.D.
National University Singapore - Professor of Biochemistry and Physiology
Michael Greve
Forever Healthy Foundation
Ronald Kohanski, Ph.D.
National Institute on Aging
Steve Horvath, Ph.D.
David Geffen School of Medicine, UCLA
Alexander Fedintsev
Institute of Biology of FRC of Komi Scientific Center
Aubrey de Grey, Ph.D.
Methuselah Foundation - Founder
Gabriela Bunu
Institute of Biochemistry of the Romanian Academy - Research Assistant
Judith Campisi, Ph.D.
Buck Institute for Age Research
Alexey Moskalev, Ph.D.
Syktyvkar State University
Jonathan Clark, Ph.D.
Babraham Institute - Biological Chemistry Faculty Head
Eric Leire, M.D.
Genflow Biosciences - CEO
Hanadie Yousef, Ph.D.
Juvena Therapeutics
Kris Verburgh, M.D.
Free University of Brussels
Tyler Golato
Molecule - CSO
Tom Weldon
Ponce De Leon Health - CEO
Gordan Lauc, Ph.D.
GlycanAge - CSO
Sajad Zalzala, M.D.
AgelessRX - Co-founder
Ronjon Nag, Ph.D.
R42 Group - President
Isabelle Schiffer, Ph.D.
Forever Healthy Foundation
David Gobel
Methuselah Foundation
EARD 2019
Aubrey de Grey, Ph.D.
Methuselah Foundation - Founder
Michael Greve
Forever Healthy Foundation
Ronald Kohanski, Ph.D.
National Institute on Aging
Doug Ethell, Ph.D.
Leucadia Therapeutics - CEO
Maria Blasco, Ph.D.
Spanish National Cancer Research Centre (CNIO) - Director
Greg Fahy, Ph.D.
Intervene Immune - CSO
Reason
Repair Biotechnologies - CEO
Kelsey Moody, Ph.D.
Ichor Therapeutics - CEO
Morgan Levine, Ph.D.
Yale School of Medicine
Michael Lustgarten, Ph.D.
Tufts University - Nutrition, Exercise Physiology, and Sarcopenia (NEPS) Team
Qingsong Zhu, Ph.D.
Insilico Medicine
Andrei Gudkov, Ph.D.
Roswell Park Comprehensive Cancer Center
James Peyer, Ph.D.
Cambrian BioPharma - CEO
Vadim Gladyshev, Ph.D.
Harvard Medical School - Professor, Medicine, Harvard Medical School
Kevin Strange, Ph.D.
Novo Biosciences - CEO
João Pedro de Magalhães, Ph.D.
University of Liverpool
Amutha Boominathan, Ph.D.
SENS Research Foundation - Group Lead, MitoSENS
EARD 2018
Steven A. Garan
Center for Research & Education on Aging - Director of Bioinformatics
Aubrey de Grey, Ph.D.
Methuselah Foundation - Founder
Kelsey Moody, Ph.D.
Ichor Therapeutics - CEO
Alvaro Macieira-Coelho, Ph.D.
French Institute of Health and Medical Research - INSERM
Michael West, Ph.D.
AgeX Therapeutics - CEO
Stephen Hilbert
Oisin Biotechnologies - CBO
Bobby Brooke
Intervene Immune - CEO
Sudhir Paul, Ph.D.
Covalent Bioscience - Co-founder
James Peyer, Ph.D.
Cambrian BioPharma - CEO
Antonei Csoka, Ph.D.
Howard University - Associate Professor
